247 related articles for article (PubMed ID: 34399001)
1. Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination.
Lim PN; Wylie G
Clin Exp Dermatol; 2022 Jan; 47(1):175-176. PubMed ID: 34399001
[TBL] [Abstract][Full Text] [Related]
2. A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination.
Manaa A; Ziv M; Krausz J; Dodiuk-Gad RP
Dermatol Ther; 2022 Jul; 35(7):e15546. PubMed ID: 35485220
[No Abstract] [Full Text] [Related]
3. Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination.
Wantavornprasert K; Noppakun N; Klaewsongkram J; Rerknimitr P
Clin Exp Dermatol; 2022 Feb; 47(2):428-432. PubMed ID: 34482558
[No Abstract] [Full Text] [Related]
4. Coix lacryma-jobi associated symmetrical drug-related intertriginous and flexural exanthema.
Choi MJ; Oh SH; Cho SB
Int J Dermatol; 2014 Apr; 53(4):e301-3. PubMed ID: 24261789
[No Abstract] [Full Text] [Related]
5. Reply to "A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination" by Manaa et al.
Camela E; Scalvenzi M; Megna M; Potestio L; Guerrasio G; Fornaro L; Fabbrocini G; Costa C
Dermatol Ther; 2022 Dec; 35(12):e15881. PubMed ID: 36181410
[No Abstract] [Full Text] [Related]
6.
Cabrera Hernandez V; Gonzalez Afonso M; Callero Viera A; Martin-Fernandez Martin L
BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31377719
[TBL] [Abstract][Full Text] [Related]
7. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) associated with pristinamycin, secnidazole, and nefopam, with a review of the literature.
Nespoulous L; Matei I; Charissoux A; Bédane C; Assikar S
Contact Dermatitis; 2018 Dec; 79(6):378-380. PubMed ID: 30062790
[No Abstract] [Full Text] [Related]
8. Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitors.
Spigariolo CB; Barei F; Maronese CA; Barberi F; Cattaneo A; Violetti SA
Australas J Dermatol; 2022 Nov; 63(4):509-512. PubMed ID: 35877187
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) confirmed by skin testing.
Hampel A; Kinaciyan T
Contact Dermatitis; 2024 May; 90(5):525-527. PubMed ID: 38263696
[No Abstract] [Full Text] [Related]
10. Symmetrical drug-related intertriginous and flexural exanthema/baboon syndrome induced by traditional Chinese medicine.
Liu J; Li LF
J Cosmet Dermatol; 2022 May; 21(5):2200-2204. PubMed ID: 34333850
[TBL] [Abstract][Full Text] [Related]
11. De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine.
Elamin S; Hinds F; Tolland J
Clin Exp Dermatol; 2022 Jan; 47(1):153-155. PubMed ID: 34398977
[TBL] [Abstract][Full Text] [Related]
12. Intertriginous eruption induced by terbinafine: a review of baboon syndrome.
Janjua SA; Pastar Z; Iftikhar N; Ammad S
Int J Dermatol; 2017 Jan; 56(1):100-103. PubMed ID: 27153516
[No Abstract] [Full Text] [Related]
13. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.
Winnicki M; Shear NH
Am J Clin Dermatol; 2011 Jun; 12(3):171-80. PubMed ID: 21469762
[TBL] [Abstract][Full Text] [Related]
14. Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients.
David R; Hanna P; Lee K; Ritchie A
Nephrology (Carlton); 2022 Jan; 27(1):109-110. PubMed ID: 34755433
[No Abstract] [Full Text] [Related]
15. Symmetrical drug-related intertriginous and flexural exanthema-like eruption: An addition to the spectrum of coronavirus disease 2019-related cutaneous findings.
Çakıcı ÖA; Güder S; Salman A; Ergun T
Indian J Dermatol Venereol Leprol; 2022; 88(6):814-816. PubMed ID: 36332096
[No Abstract] [Full Text] [Related]
16. Symmetrical drug-related intertriginous and flexural exanthema-like eruption after COVID-19 vaccine.
Lahouel I; Ben Salah N; Ben Fadhel N; Chahed F; Ouni N; Belhadjali H; Aouam K; Zili J
J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):e597-e599. PubMed ID: 35344627
[No Abstract] [Full Text] [Related]
17. Symmetrical drug-related intertriginous and flexural exanthema secondary to topical 5-fluorouracil.
Powers R; Gordon R; Roberts K; Kovach R
Cutis; 2012 May; 89(5):225-8. PubMed ID: 22768435
[TBL] [Abstract][Full Text] [Related]
18. Pustulobullous variant of SDRIFE (symmetrical drug-related intertriginous and flexural exanthema).
Magnolo N; Metze D; Ständer S
J Dtsch Dermatol Ges; 2017 Jun; 15(6):657-659. PubMed ID: 28514083
[No Abstract] [Full Text] [Related]
19. Symmetric drug-related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature.
Schuler AM; Smith EH; Chaudet KM; Bresler SC; Gudjonsson JE; Kroshinsky D; Nazarian RM; Chan MP
J Cutan Pathol; 2021 Dec; 48(12):1471-1479. PubMed ID: 34159622
[TBL] [Abstract][Full Text] [Related]
20. Symmetric drug-related intertriginous and flexural exanthema-like eruption related to coronavirus disease 2019 vaccine.
Hong JK; Shin SH; Yoo KH; Li K; Seo SJ
Contact Dermatitis; 2022 Jul; 87(1):91-93. PubMed ID: 35243643
[No Abstract] [Full Text] [Related]
[Next] [New Search]
